期刊文献+

鸡IFN-γ DNA壳聚糖纳米粒的制备及外源基因表达 被引量:1

Preparation of chicken gamma-IFN DNA-Chitosan nanoparticles for gene expression in vitro
下载PDF
导出
摘要 为检测纳米载体对表达重组质粒的保护效果,本实验构建了鸡γ干扰素(IFN-γ)真核表达重组质粒pCAGGS-ChIFN-γ;并将其与200μg/mL壳聚糖醋酸溶液制备成DNA/壳聚糖纳米颗粒(CNPs)。透射电镜观察CNPs呈不规则球形,光子相关色谱(PCS)仪测定显示CNPs的平均粒径为172.6nm±5.1nm;Zeta电位为20.8mV±2.9mV;CNPs重组质粒包埋效率和载药量分别为91.21%±2.54%和31.93%±0.16%。鸡胚成纤维细胞(CEF)体外转染实验表明:携带的外源基因能在CEF中释放、表达,其表达效率约为阳离子脂质体转染试剂LipofectamineTM 2000转染后的16.3%,同时CNPs对细胞基本无毒性。CNPs稳定实验也证实其稳定性良好。 In present study,the protection of nanoparticles on recombinant plasmid was investigated by evaluating the DNA-chitosan nanoparticles(CNPs) carrying chicken interferon-γ(ChIFN-γ) recombinant plasmid.The nanoparticles were spherical shape with a mean diameter of 1726 nm under the electronic microscope and had the Zeta potential of 20.8 mV ±2.9 mV measured by the Photon Correlation Spectroscopy(PCS).The encapsulation efficiency of DNA was 91.21 %±2.54 % and the DNA content in the nanoparticles was 31.93 %±0.16 %.The capsulated DNA could be protected from the degradation by DNaseⅠ.The transfection efficiency of CNPs was about 16.3% of that the LipofectamineTM 2000 reagent.Our results also showed that CNPs could express successfully in the CEF cells,and were nontoxic to cultured cells.
出处 《中国预防兽医学报》 CAS CSCD 北大核心 2010年第7期559-562,共4页 Chinese Journal of Preventive Veterinary Medicine
基金 国家高科技发展计划(863)项目(2006AA10A203) 黑龙江省自然科学基金重点项目(ZJN-0602-01)
关键词 壳聚糖 纳米颗粒 鸡γ-干扰素基因 体外转染 Chitosan Nanoparticals ChIFN-γ gene transfection
  • 相关文献

参考文献10

二级参考文献50

  • 1贾立军,刘秀梵,张艳梅,彭大新,张如宽.鸡γ干扰素对H5亚型禽流感疫苗的免疫增强作用[J].农业生物技术学报,2004,12(4):427-430. 被引量:13
  • 2姜永萍,张洪波,步志高,李呈军,赵有淑,王秀荣,于康震,陈化兰.表达载体pCAGGS显著增强禽流感DNA疫苗的免疫保护效果[J].中国农业科学,2006,39(4):825-830. 被引量:29
  • 3孙永科,田占成,王云峰,刘胜旺,童光志,智海东,王玫.表达鸡γ-干扰素和传染性支气管病毒S1基因的重组鸡痘病毒疫苗对鸡外周血T淋巴细胞动态分布影响的研究[J].中国预防兽医学报,2006,28(5):539-543. 被引量:12
  • 4关丽 李国明 黄晓燕.J South China Normal Unv(Nat SciEdn)(华南师范大学学报(自然科学版))[J],2001,2(1):79-79.
  • 5王亚敏 石庭森 蒲永林.Acta Pharm Sin(药学学报)[J],1996,31(4):300-300.
  • 6Bazer F W. Mediators of maternal recognition of pregnancy in mammals (J). Proceedings of the Society for Experimental Biology and Medicine, 1992, 199:373-384.
  • 7Bu Z G, Ling Y, Marianne J S, Ziegler H K, Richard W C and Yang C L. Enhancement of immune response to an HIV env DNA vaccine by a C-terminal segment of Listeriolysin O (J). AIDS Research and Human Retrovimses, 2003, 19:409~420.
  • 8Chen Z, Sahashi Y, Matsuo K, Asanuma H, Takahashi H, Iwasaki T, Suzuki Y, Aizawa C, Kurata T and Tamura S. Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza (J). Vaccine, 1998, 16: 1544-1549.
  • 9Graham S, Jacqueline D R, Andrew J R, Sean M A, Andrew J P and Paul B. Characterization of Severe acute respiratory syndromeassociated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry (J). Proceedings of the National Academy of Sciences of the USA, 2004, 101: 4240-4245.
  • 10lsaacs A and Lindenmann I. Virus interference: The Interferon (J). Proceedings of the Royal Society of London. Series B, 1957, 147:258-267.

共引文献83

同被引文献4

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部